Stockreport

Inspire Medical, ResMed decline following Lilly tirzepatide sleep apnea data [Seeking Alpha]

ResMed Inc.  (RMD) 
Last resmed inc. earnings: 4/30 04:05 pm Check Earnings Report
PDF released after the closing bell on June 21 of Eli Lilly's ( LLY ) diabetes and weight loss drug tirzepatide as a sleep apnea treatment. Inspire manufactures an implant [Read more]